Dimensional Fund Advisors
ACET icon

Dimensional Fund Advisors’s Adicet Bio ACET Stock Holding History

Dimensional Fund Advisors’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$273K Buy
31,603
+20,825
+193% +$164K ﹤0.01% 3043
2026
Q1 		$73.4K Buy
+10,778
New +$80.7K ﹤0.01% 3140
2025
Q4 		– Sell
-3,310
Closed -$42.9K – 3241
2025
Q3 		$42.9K Sell
3,310
-269
-8% -$3.17K ﹤0.01% 3247
2025
Q2 		$34.9K Sell
3,579
-5,659
-61% -$59.7K ﹤0.01% 3253
2025
Q1 		$112K Hold
9,238
– – ﹤0.01% 3193
2024
Q4 		$142K Hold
9,238
– – ﹤0.01% 3198
2024
Q3 		$213K Hold
9,238
– – ﹤0.01% 3162
2024
Q2 		$179K Sell
9,238
-2,595
-22% -$69.5K ﹤0.01% 3183
2024
Q1 		$445K Buy
11,833
+2,245
+23% +$92.9K ﹤0.01% 3063
2023
Q4 		$290K Sell
9,588
-469
-5% -$10.2K ﹤0.01% 3141
2023
Q3 		$221K Sell
10,057
-10,500
-51% -$371K ﹤0.01% 3202
2023
Q2 		$799K Sell
20,557
-14,341
-41% -$1.27M ﹤0.01% 2965
2023
Q1 		$3.22M Buy
+34,898
New +$4.38M ﹤0.01% 2612
2022
Q3 		$5.54M Buy
24,370
+12,888
+112% +$3.27M ﹤0.01% 2390
2022
Q2 		$2.68M Buy
11,482
+6,569
+134% +$1.44M ﹤0.01% 2650
2022
Q1 		$1.57M Buy
4,913
+3,239
+193% +$745K ﹤0.01% 2883
2021
Q4 		$468K Buy
1,674
+108
+7% +$18.5K ﹤0.01% 3180
2021
Q3 		$197K Sell
1,566
-621
-28% -$77K ﹤0.01% 3351
2021
Q2 		$360K Buy
+2,187
New +$445K ﹤0.01% 3229

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Dimensional Fund Advisors's ACET Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Adicet Bio (ACET) stake by 193% in Q2 2026, buying an estimated $164K and bringing the position to 31,603 shares worth $273K. The position accounts for ﹤0.01% of the portfolio, ranked #3043.

Dimensional Fund Advisors first reported a position in ACET in Q2 2021 and has held it in 19 quarters since. The position peaked at $5.54M in Q3 2022. 56 funds tracked by Wall St. Rank hold ACET as of Q2 2026.

  • Dimensional Fund Advisors held 31,603 shares of Adicet Bio worth $273K as of Q2 2026.
  • Dimensional Fund Advisors bought 20,825 Adicet Bio shares in Q2 2026, an estimated $164K.
  • Adicet Bio made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #3043 holding.
  • Dimensional Fund Advisors first reported a position in Adicet Bio in Q2 2021 and has held it in 19 quarters since.
  • Dimensional Fund Advisors's Adicet Bio position peaked at $5.54M in Q3 2022.
  • 56 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.